Member Info for T0n1c

I'm inclined to trust Colin and his team to have planned in resource costs, as well as equipment. Certainly more than I'm prepared to read your drivel.

Colin has even stated there are no plans for another placing.
Go back and watch/read the investor presentations.... if you're prepared to actually be an investor.

Also, Colin and Co. had already set aside ~£4m for the expansion plans... in addition to the £7m in the bank.

Blacksheep was gone.

Everyone, view the presentation:
https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Slide 7:
At the end of September Omega had £7m in the bank and a £2m overdraft available.

Agreed... well said BigJock

Everyone, view the presentation:
https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information
Slide 7:
At the end of September Omega had £7m in the bank and a £2m overdraft available.

"Learn to spell, and stop telling porkies, your failing miserably."

You're...!

Irony.

In addition to the list of pending news below, there was a lot of new stuff surfacing last week. New dots being joined.
* Talk of a UK manufacturing consortium/collaboration
* Code snippets indicating ABC-19 test to be used at home
* Gov videos published on how to self-test with an antigen test
* My favourite, Deeks being slammed publicly, with strong support and justification of LFTs in the press.

News that we kinda know about, and seek updates on are
* Visitect CD4 sales (NGO orders for the year ahead should hopefully now be approved/confirmed)
* Food detective sales (China in particular)
* Covid - Visitect triple antibody test sales (There’s been some twitterers highlighting UK offerings to the market. Anything global too, I wonder)
* Covid - UK-RTC - confirmation of orders
- To UK GOV
- To other interested parties (better margins for Omega than to UK GOV)
* Covid - ELISA antibody testing (Omega were looking to setup a lab service)
* Confirmation of upscaled production to 500k per week (at end of December), and on plan with further expansion – The tweet this week implied all was on track
* Potential new news on further increased production - Anything on top of the planned 2m per week? There seemed to be a lot of space in the Alva site that could hopefully accommodate more equipment.
* Progress on Tech Transfer and CE mark of the Mologic Antigen test (This must be close now)
* In addition to tech transferring the Antigen in under the Vistect brand, are there other arrangements in place to manufacture for/with Mologic? There was some mention of mystery funding in the 30th November presentation.
* MHRA approval for ABC-19 self-test
* Updates from 76 (I think) countries on validation of numerous tests
* AVCT development tie-up - whats the deal?
* Any commitment/collaboration with OX/AZ vaccine deployment

It’s looking like a very good week, or several, ahead.

GLA

MIK, I'm not suer you fully understand the revenue streams.
In fact nobody really does yet, with all the news in the last week, ands potential of a UK manufacturing setup.
But, in the consortium you write of, we will manufacture NO LESS than 25%.
The last we were told, come April, Omegas plans are to only allocate 10% of manufacturing to that arrangement.
The rest, 1.8m per week, will be put towards other tests (likely Antigen) that will recognise higher margin.
I agree, we do need to understand what the plan for production is, and what margins to expect, once orders are published.
Worth also noting that when we were informed of the last RTC order, we were receiving higher margin than previously planned.
It's highly likely;y, in Colins under promise over deliver way, that we will see higher margins then we've previously been told for other tests too.

GLA

Sir Patrick Vallance during this evenings update:

"Get vaccines out there, and measure, measure, measure"

All going to plan, which I'm sure it is, we are at 500k pw as at end of December, targeting 600k pw by the end of January.
The 30th November presentation has more details, and is well worth a watch/listen.
https://webcasting.brrmedia.co.uk/broadcast/5fbf9d78b19325729a9d7d05/5fc522050c7aa22257c26c99

"John Deeks has 'clarified' to say that he didn't mean what he said."

What an absolute Deek!

Promoting the use of LFT against PCR (too sensitive), and disputing the BMJ article.
There is so much positive news around LFT at the moment.

"A vital tool in combating the virus"

Isn't it just.
30th November - Detailed scale up and production plans completed
* ODX announced to investors, the plan to expand to 2m a week BY April, on the 30th November. There will have no doubt have been a detailed plan behind that announcement (twitter yesterday is evidence of that).

30th November - Complete ordering of (LFT) production equipment
* We saw the GOV tender for the additional equipment. We're yet to have confirmation (if indeed we'll get it) that ODX were recipients of some of that kit. It's highly likely they were. (twitter yesterday is supportive of that theory).

31st January - pre-scale up production testing with selected UK manufacturers
* The tweet yesterday "We've also taken delivery of a large amount of tooling to facilitate production, to be rolled-out WITHIN DAYS." would indicate by the end of next week.

So many dots being joined. Colin surely has to be thinking beyond 2M by April already.

Thanks Big Jock.. always good to see a post from you.

Real, I don't understand why you only post on ODX, particularly when you have sold up.
Did you not invest your losses elsewhere?
Do get pleasure in just posting anonymous needless comments on a BB with no interest in the subject what so ever?
Odd character.

I was wondering the same BigJock.
For someone so allegedly invested, Junior sure has a lot of anger and bad words to say of their own investment.

Can anyone find a list of FDA approved antibody tests?
I'm still looking, but can't find it.

Worst case - When it comes to April, and we're at our 2m per week (not considering any higher capacity that may be being planned for), the ABC-19 test is just 10% of our output.

BUT.. in the last week alone there is lots of evidence of coding for apps that references the ABC-19, for home use, along with views that the test won't really be needed until April time anyway, to support the 2nd vaccine jab process.

Not forgetting also that ODX have almost doubled their workforce, are expanding their office/production space (by the reading of it).

This is a lot of noise, that may impact the SP first thing tomorrow, but as a LTH.. no worries mate.

DYOR

I'll leave this here again...

As a reminder to those interested, and anyone new around here, news is 'still' pending on a number of fronts.
There's been some interesting dots being joined toward a further UK manufacturing consortium/collaboration on the Antigen test front.
News that will have the biggest impact to the SP are obviously related to sales, with a number of revenue streams available, not just Covid, to Omega:
* Visitect CD4 sales (NGO orders for the year ahead should hopefully now be approved/confirmed)
* Food detective sales (China in particular)
* Covid - Visitect triple antibody test sales (There’s been some twitterers highlighting UK offerings to the market. Anything global too, I wonder)
* Covid - UK-RTC - confirmation of orders
- To UK GOV - With the voluntary withdrawal from US FDA, does that mean the UKGOV are seeking all tests for themselves?
- To other interested parties (better margins for Omega than to UK GOV)
* Covid - ELISA antibody testing (Omega were looking to setup a lab service)

Other key updates pending:
* Confirmation of upscaled production to 500k per week (at end of December), and on plan with further expansion
* Potential new news on further increased production - Anything on top of the planned 2m per week?
* Progress on Tech Transfer and CE mark of the Mologic Antigen test (This must be close now)
From the Investor presentation, 30th November;
https://webcasting.brrmedia.co.uk/broadcast/5fbf9d78b19325729a9d7d05
19'20" onwards - "In terms of the technical transfer. As promised we have commenced that work, with Mologic, to bring the test into Alva".... " We expect that work to complete early in the new year, and importantly sales to commence early in the new year as well".
FYI, the Triple antibody T&T from Mologic took ~4 weeks.
* In addition to tech transferring the Antigen in under the Vistect brand, are there other arrangements in place to manufacture for/with Mologic? There was some mention of mystery funding in the 30th November presentation.
* MHRA approval for ABC-19 self-test
* Updates from 76 (I think) countries on validation of numerous tests
* AVCT development tie-up - whats the deal?
* Still need confirmation that Anthony retained his job after his linked-in profile update (flagging the AVCT tie-up)
* Any commitment/collaboration with OX/AZ vaccine deployment
Maybe more…

I'm inclined, for obvious reasons, to trust Colin and the team in what they are doing, expanding LFT production capacity, near doubling the team, still hiring more staff, than listen to baseless noise from various BB contributors.
I appreciate I am one of those, so take the above as you so wish.

DYOR

Spot on kfordearp.
Mologic/GAD and ODX will be selling in different markets.